NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats

NeuroToxicology

Volumn 36, Issue , 2013, Pages 17-23

  Bu, Qian ^a   Lv, Lei ^a   Yan, Guangyan ^a   Deng, Pengchi ^b   Wang, Yanli ^c   Zhou, Jiaqing ^a   Yang, Yanzhu ^a   Li, Yan ^a   Cen, Xiaobo ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Sichuan Women and Children's Hospital   (China)

Author keywords

Locomotor activity; Metabonomic; Methamphetamine; NMR

Indexed keywords

2 OXOGLUTARIC ACID; 4 AMINOBUTYRIC ACID; ACETYLCYSTEINE; ADENOSINE DIPHOSPHATE; CITRIC ACID; DOPAMINE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; HOMOCYSTEIC ACID; INOSITOL; METHAMPHETAMINE; METHIONINE; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; SEROTONIN; SUCCINIC ACID; SUCCINIC SEMIALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMICS; BRAIN METABOLISM; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; GLIOSIS; HIPPOCAMPUS; LOCOMOTION; MALE; MEMBRANE DAMAGE; METABONOMICS; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PARTIAL LEAST SQUARES REGRESSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM SENSITIZATION; CENTRAL NERVOUS SYSTEM STIMULANTS; DISCRIMINANT ANALYSIS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; METHAMPHETAMINE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; TRITIUM;

EID: 84875255036     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.02.007     Document Type: Article

References (60)

1. Achat-Mendes C., Anderson K., Itzhak Y. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Neuropsychopharmacology 2006, 32:531-541.
2. Akiyama K., Ujike H., Sakai K., Shimizu Y., Kodama M., Kuroda S. Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocaine-induced behavioral sensitization. Pharmacol Biochem Behav 1998, 61:419-426.
3. Brady A., Glick S., O'Donnell P. Selective disruption of nucleus accumbens gating mechanisms in rats behaviorally sensitized to methamphetamine. J Neurosci 2005, 25:6687.
4. Brown J., Yamamoto B. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 2003, 99:45-53.
5. Chandra G., Gangopadhyay P., Senthil Kumar K., Mohanakumar K. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats. Brain Res 2006, 1075:81-92.
6. Chandramani Shivalingappa P., Jin H., Anantharam V., Kanthasamy A. N-Acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells. Parkinson's Dis 2012, 2012:424285.
7. Chang L., Cloak C., Jiang C., Farnham S., Tokeshi B., Buchthal S., et al. Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 2009, 48:391-397.
8. Chang L., Ernst T., Speck O., Grob C. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 2005, 162:361.
9. Ernst T., Chang L. Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol 2008, 3:165-172.
10. Ferrario C., Li X., Wang X., Reimers J., Uejima J., Wolf M. The role of glutamate receptor redistribution in locomotor sensitization to cocaine. Neuropsychopharmacology 2010, 35:818-833.
11. Fukami G., Hashimoto K., Koike K., Okamura N., Shimizu E., Iyo M. Effect of antioxidant N-acetyl-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res 2004, 1016:90-95.
12. 1H NMR spectroscopy. Neurochem Int 2007, 50:386-394.
13. Gluck M.R., Moy L.Y., Jayatilleke E., Hogan K.A., Manzino L., Sonsalla P.K. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 2008, 79:152-160.
14. Harvey D., Lacan G., Tanious S., Melega W. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 2000, 871:259-270.
15. Hatzipetros T., Raudensky J., Soghomonian J., Yamamoto B. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata. J Neurosci 2007, 27:5895.
16. Huang C., Liang Y., Lee C., Wu M., Hsu K. Repeated cocaine administration decreases 5-HT2A receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex. Neuropsychopharmacology 2009, 34:1979-1992.
17. Iwazaki T., McGregor I., Matsumoto I. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. Neurosci Lett 2008, 435:113-119.
18. Kaddurah-Daouk R., Krishnan K. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2008, 34:173-186.
19. Kitanaka N., Kitanaka J., Takemura M. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 2003, 474:63-70.
20. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009, 60:379-407.
21. Kruman I., Culmsee C., Chan S., Kruman Y., Guo Z., Penix L., et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000, 20:6920.
22. Kuczenski R., Segal D., Melega W., Lacan G., McCunney S. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge. Neuropsychopharmacology 2009, 34:2430-2441.
23. Lan K.C., Chang A.C., Liu S.H., Ho I.K., Lin-Shiau S.Y. Enhancing effects of morphine on methamphetamine-induced reinforcing behavior and its association with dopamine release and metabolism in mice. J Neurochem 2009, 109:382-392.
24. Lan M., McLoughlin G., Griffin J., Tsang T., Huang J., Yuan P., et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 2008, 14:269-279.
25. Lodge D., Grace A. Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. J Neurosci 2008, 28:7876.
26. Lotharius J., Falsig J., van Beek J., Payne S., Dringen R., Brundin P., et al. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 2005, 25:6329.
27. Manji H., Moore G., Rajkowska G., Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 2000, 5:578-593.
28. Mao L.M., Fibuch E.E., Wang J.Q. Decoding BDNF-LTP coupling in cocaine addiction. Neuron 2010, 67:679-681.
29. McDaid J., Graham M.P., Napier T.C. Methamphetamine-induced sensitization differentially alters pCREB and ΔFosB throughout the limbic circuit of the mammalian brain. Mol Pharmacol 2006, 70:2064-2074.
30. Mizuno M., Kawamura H., Ishizuka Y., Sotoyama H., Nawa H. The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats. Pharmacol Biochem Behav 2010, 97:392-398.
31. 13C-MRS to research on brain metabolism. NMR Biomed 2003, 16:303-312.
32. Moszczynska A., Fitzmaurice P., Ang L., Kalasinsky K., Schmunk G., Peretti F., et al. Why is parkinsonism not a feature of human methamphetamine users?. Brain 2004, 127:363.
33. Ni Y., Su M., Lin J., Wang X., Qiu Y., Zhao A., et al. Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Lett 2008, 582:2627-2636.
34. Nordahl T., Salo R., Natsuaki Y., Galloway G., Waters C., Moore C., et al. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2005, 62:444.
35. Patkar A.A., Rozen S., Mannelli P., Matson W., Pae C.U., Krishnan K.R., et al. Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berlin) 2009, 206:479-489.
36. 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease. J Biol Chem 2005, 280:42508-42514.
37. Perez M., Gabach L., Almiron R., Carlini V., De Barioglio S., Ramirez O. Different chronic cocaine administration protocols induce changes on dentate gyrus plasticity and hippocampal dependent behavior. Synapse 2010, 64:742-753.
38. Pham J., Cabrera S., Sanchis-Segura C., Wood M. Automated scoring of fear-related behavior using EthoVision software. J Neurosci Methods 2009, 178:323-326.
39. Plumb R., Granger J., Stumpf C., Wilson I.D., Evans J.A., Lenz E.M. Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst 2003, 128:819-823.
40. Salek R., Colebrooke R., Macintosh R., Lynch P., Sweatman B., Emson P., et al. A metabolomic study of brain tissues from aged mice with low expression of the vesicular monoamine transporter 2 (VMAT2) gene. Neurochem Res 2008, 33:292-300.
41. Salo R., Nordahl T., Natsuaki Y., Leamon M., Galloway G., Waters C., et al. Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 2007, 61:1272-1280.
42. Sarker S., Weissensteiner R., Steiner I., Sitte H.H., Ecker G.F., Freissmuth M., et al. The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Mol Pharmacol 2010, 78:1026.
43. Scholl J., Feng N., Watt M., Renner K., Forster G. Individual differences in amphetamine sensitization, behavior and central monoamines. Physiol Behav 2009, 96:493-504.
44. Simoes P., Silva A., Pereira F., Marques E., Grade S., Milhazes N., et al. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 2007, 150:433-441.
45. Smith K., Self R., Butler T., Mullins M., Ghayoumi L., Holley R., et al. Methamphetamine exposure antagonizes N-methyl-d-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures. Brain Res 2007, 1157:74-80.
46. Staszewski R.D., Yamamoto B.K. Methamphetamine-induced spectrin proteolysis in the rat striatum. J Neurochem 2006, 96:1267-1276.
47. Sung Y., Cho S., Hwang J., Kim S., Kim H., Bae S., et al. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug Alcohol Depend 2007, 88:28-35.
48. Szumlinski K.K., Balogun M.Y., Maisonneuve I.M., Glick S.D. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats. Psychopharmacology (Berlin) 2000, 151:234-241.
49. Thomas D.M., Francescutti-Verbeem D.M., Kuhn D.M. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 2007, 105:605-616.
50. Thomas D.M., Francescutti-Verbeem D.M., Kuhn D.M. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity. J Neurochem 2009, 109:1745-1755.
51. 1H NMR spectroscopy. Toxicol Appl Pharmacol 2009, 234:314-325.
52. Wikoff W., Pendyala G., Siuzdak G., Fox H. Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest 2008, 118:2661.
53. Winsberg M., Sachs N., Tate D., Adalsteinsson E., Spielman D., Ketter T. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000, 47:475-481.
54. Wishart D.S., Tzur D., Knox C., Eisner R., Guo A.C., Young N., et al. HMDB: the human metabolome database. Nucleic Acids Res 2007, 35:D521.
55. Xiang Y., Gao H., Zhu H., Sun N., MA Y., Lei H. Neurochemical changes in brain induced by chronic morphine treatment: NMR studies in thalamus and somatosensory cortex of rats. Neurochem Res 2006, 31:1255-1261.
56. Yamamoto B., Bankson M. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol 2005, 17:87.
57. Yao J., Reddy R. Metabolic investigation in psychiatric disorders. Mol Neurobiol 2005, 31:193-203.
58. Zhang X., Liu H., Wu J., Liu M., Wang Y. Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats. Neurochem Int 2009, 54:481-487.
59. Zhou J., Li Y., Yan G., Bu Q., Lv L., Yang Y., et al. Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress. Neurotox Res 2011, 20:334-342.
60. Zou J.Y., Crews F.T. TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF-κB inhibition. Brain Res 2005, 1034:11-24.